| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |